Kolexia
Collot Thomas Oncologie médicale
Collot Thomas
Oncologie médicale
Hôpital William Morey
Chalon-sur-Saône, France
42 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs du foie Tumeurs neuroendocrines Tumeurs de l'ovaire Métastase tumorale Métastase lymphatique {{person.topmesh8.name}} {{person.topmesh9.name}} {{person.topmesh10.name}}

Collaborateurs

Voir plus
Diaz Pierre
Diaz Pierre
Hôpital William Morey, Chalon-sur-Saône, France
Letellier Mélanie
Letellier Mélanie
Hôpital William Morey, Chalon-sur-Saône, France
Ghirardi Sarah
Ghirardi Sarah
Centre Georges-François Leclerc, Dijon, France
Nguyen-Baranoff Daniele
Nguyen-Baranoff Daniele
Hôpital William Morey, Chalon-sur-Saône, France

Industries

Voir plus
AstraZeneca
11 collaboration(s)
Dernière en 2023
MSD
8 collaboration(s)
Dernière en 2023
Ipsen
5 collaboration(s)
Dernière en 2022
Janssen
3 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
SAFIR 03: A ctDNA Screening Program in Patients With HR+, HER2- Metastatic Breast Cancer for Detection of High-risk Relapse Patients on Any CDK4/6 Inhibitor and a Randomised Phase II Study Comparing Alpelisib Combined With Fulvestrant to Ribociclib Combined With Fulvestrant, in Patients With Persistent Targetable PIK3CA Mutations
Essai Clinique (Unicancer)   20 novembre 2023
Quality of life and perceived burden of the primary caregiver of patients aged 70 and over with cancer 5 years after initial treatment.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer   02 février 2023
An Algorithm Combining Patient Performance Status, Second Hit Analysis, PROVEAN and Dann Prediction Tools Could Foretell Sensitization to PARP Inhibitors in Digestive, Skin, Ovarian and Breast Cancers.
Cancers   22 juin 2021
FARAPPAC: Perceived Burden and Quality of Life of Primary Caregivers of Cancer Patients Aged 70 and Older After 5 Years of Management
Essai Clinique (CHU Dijon-Bourgogne)   09 mars 2021
PARP inhibitor resistance and TP53 mutations in patients treated with olaparib for BRCA-mutated cancer: Four case reports.
Molecular medicine reports   25 novembre 2020
Implementation and use of whole exome sequencing for metastatic solid cancer.
EBioMedicine   07 janvier 2020
Bevacizumab-based Chemotherapy for Poorly-differentiated Neuroendocrine Tumors.
Anticancer research   11 octobre 2018
{{person.lastact8.name}}
{{person.lastact8.jour}}   {{person.lastact8.date}}
{{person.lastact9.name}}
{{person.lastact9.jour}}   {{person.lastact9.date}}
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}